Digital Distribution & Reach
IPT is channeled through across the PMGroup network of print and digital publications and events:
IPT Subscribers
● 3,598 opt-in subscribers to the magazine
● 3 monthly emails per issue
● Articles and advertorials listed with direct access from email
● Direct links to desktop and mobile friendly content
Other direct distribution
New edition notification included on the following emails:
● PMPS: 8,902 subscribers
● ICT: 3,681 subscribers
● EBR: 3,763 Subscribers
● PharmaTimes Week In Review: 7,300 subscribers
● PMLiVE Week in Review: 5,200 subscribers
● Pharmafile: 2,874 subscribers
Advertising and Promotion
New edition adverts uploaded to: iptonline.com - 6,000 monthly visitors samedanltd.com - 5,000 monthly visitors pharmatimes.com - 44,000 monthly visitors PMLiVE.com - 41,000 monthly visitors *Google Analytics Unique Users August 2025
Social Media Distribution
X followers:
@IPTmag - 938
@EBRmagazine - 947
@IntClinTrials - 2,254
@PMPSmag - 940
@pharmatimes - 57,780
@pharmafocus - 48,719
@PMLiVEcom - 15,693
Linkedin followers:
Samedan Ltd - 775
Innovations in Pharmaceutical Technology - 318
European Biopharmaceutical Review - 372
Pharmafile.com - 1,041
PMGroup Worldwide Ltd - 1,000
PharmaTimes Media - 13,000 followers
Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.